Pain, Postoperative Clinical Trial
Official title:
The Influence of Different Doses of Local Anesthetic on the Distribution of Anesthesia of the Lateral Femoral Cutaneous Nerve - a Randomized, Blinded, Paired Study of Healthy Individuals
The purpose of this study is to investigate and describe the anatomical differences in distribution of the blocked area following a perineural LFCN (Lateral Femoris Cutaneous Nerve) block with either 8 ml or 16 ml of Ropivacaine, in relation to incision lines used in THA (Total Hip Arthroplasty). Furthermore, we examine any loss of motor function in Musculus Quadriceps due to posible involvement of the Femoral Nerve. This trial will be conducted in healthy volunteers, as a blinded, randomized, paired trial.
Background:
Total hip arthroplasties may be associated with moderate to intense postoperative pain. It
is essential that pain treatment, besides being analgesic, has a minimum of side effects,
especially those opioid-related, in order to achieve low morbidity, high patient
satisfaction and to encourage the functional rehabilitation.
Currently, there is no "gold standard" for pain treatment after THA, and there exists a
large variety of treatment options. Some patients who have undergone THA, can be difficult
to sufficiently treat with conventional analgesics without reaching additional morphine
doses where side effects are unacceptable. It is therefore important to explore other
treatment options, including nerve blockade.
Nerve blocks have previously been used after THA operations, but have been hampered by the
fact, that the nerve blocks have an effect on the motorial nerve, inhibiting early
mobilization and possibly increasing tendencies to fall when mobilized. The Lateral Femoral
Cutaneous Nerve (LFCN) is purely sensorial and can therefore relieve the patient of pain
without influencing the early mobilization.
In two previous trials, the investigators have studied the effect of LFCN blocks in pain
treatment after THA. In the recent study, the LFCN block was applied in patients after THA,
who still had visual analogue scale (VAS) mobilization pain > 40 mm when lifting their leg
stretched. The LFCN block alleviated significantly the average pain at group level.
Meanwhile 42% of patients in the study had no or limited effect of the block. The reason for
this may be due to the fact, that LFCN block does not cover all types of pain after THA, but
also the fact, that the nerve innervation area has individual differences in the anatomical
distribution. We are currently investigating this matter in another study.
LFCN arise from the lumbar plexus, L1-L3. It progresses profound to m. psoas major and over
m. iliacus towards the anterior superior iliac spine (ASIS). LFCN perforates the inguinal
ligament in varying distance from the ASIS. Afterwards it makes a roughly 90 degrees lateral
turn, divides into 3-5 branches and innervates skin lying on the lateral, proximal part of
the leg. LFCN is found to have multiple anatomical variations therefore it is described to
innervate both the lateral, as well as the anterior, parts of the thigh.
A single study has described LFCN as being placed in it's own canal created by a splitting
of the Iliac Fascia creating a lumen in which the nerve lies. Therefore, it is hypothesized
that a larger injection volume of local anaesthetic could migrate both proximal and distal
within the above-described canal, spreading to additional local cutaneous nerves arising
from LFCN, or even other nerves (iliohypogastric, ilioinguinal or subcostal), thereby giving
rise to a greater blocked distribution area. An unwanted result of a larger injection volume
is the possibility of involvement of the femoral nerve, which would result in motoric
blockage of the Quadriceps muscle. It has previously been described that Iliac fascia block
(injection profound to the iliaca fascia) has a great diversity in area distribution as well
as blockage of the femoral nerve. By injecting the local anaesthetic directly into LFCN own
canal we seek to minimize the risk of femoral nerve involvement.
Methods:
Prior to applying the nerve block, the measurement methods are tested and baseline values
are registered for each leg of each participant.
The effect of a nerve block in healthy individuals can be studied by a number of validated
measurement techniques. These techniques consist of mapping the affected anatomical area
with temperature discrimination test (cold sensation) by using alcohol soaked gauze and
pin-prick test by using a Von Frey filament, and of pain during tonic heat-stimulation of
the skin (VAS tonic heat stimulation). The distribution of the sensory block is thus
evaluated by high precision.
It is furthermore important to investigate whether the nerve blockade affects the femoral
nerve's motorial innervation by testing m.Quadriceps' motoric function.
Course of study:
1. Baseline values are measured.
2. An orthopedic surgeon draws two hypothetical incisional lines corresponding to the
posterior and to the anterior-lateral access to the hip joint on each leg of each
participant. The incisional lines will be drawn with UV paint only visible under UV
light. No other than the person drawing the lines and the participant will see where
the lines are drawn.
3. An ultrasound guided LFCN block is then applied by a doctor with extensive experience
in applying ultrasound guided blocks. Each trial participant will get two injection of
Ropivacaine 0.75%. 8 ml in one leg and 16 ml in the other leg. Neither trial
participants, doctors,investigator or outcome assessors will know which volume the
participant receives in which leg, that is the trial is blinded.
4. After the LFCN block is applied a line called "Line A" is drawn on each leg. Line A
goes from trochanter major to the femoral lateral epicondyle and is extended cranial. A
line 0A is drawn perpendicular on line A at the trochanter major point. 5 cm above line
0A, is line -1A drawn up to -3A, and 5 cm below line 0A is line 1A drawn, and so forth
to line 15A is reached.
5. One hour after the nerve block is applied to the right leg, the motorial and sensorial
tests will be carried out on each leg, and the outcome will be registered and
documented with photography. The test will be carried out on the right leg and then on
the left leg in following order:
- Maximum isometric voluntary contraction
- Temperature discrimination test (alcohol soaked gauze)
- Pin-prick (Von Frey filament)
- Photo documentation
- Drawing of the incisional lines under UV-light
- Photo documentation
- Measurement of the incisional lines
- Pain stimulation test. The subjects will be monitored with blood pressure, pulse
oximetry and ECG during the trial. The study extends for each participant from the
introductory conversation to all testing is complete.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05480111 -
The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy
|
Phase 4 | |
Completed |
NCT06129305 -
Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
|
||
Completed |
NCT04401826 -
Micro-surgical Treatment of Gummy Smile
|
N/A | |
Recruiting |
NCT04020133 -
the Role of Popliteal Plexus Block in Pain Management After Anterior Cruciate Ligament Reconstruction.
|
N/A | |
Completed |
NCT03023462 -
Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair
|
N/A | |
Completed |
NCT03652103 -
Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy
|
Phase 4 | |
Completed |
NCT03546738 -
Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery
|
N/A | |
Terminated |
NCT03261193 -
ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain
|
Phase 3 | |
Withdrawn |
NCT03528343 -
Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy
|
Phase 1/Phase 2 | |
Completed |
NCT02525133 -
Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty
|
Phase 3 | |
Completed |
NCT03244540 -
Regional Analgesia After Cesarean Section
|
Phase 4 | |
Enrolling by invitation |
NCT05316168 -
Post Operative Pain Management for ACL Reconstruction
|
Phase 3 | |
Recruiting |
NCT04130464 -
Intraperitoneal Infusion of Analgesic for Postoperative Pain Management
|
Phase 4 | |
Enrolling by invitation |
NCT04574791 -
Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty
|
N/A | |
Completed |
NCT04526236 -
Influence of Aging on Perioperative Methadone Dosing
|
Phase 4 | |
Completed |
NCT04073069 -
Scalp Infiltration With Diprospan Plus Ropivacaine for Postoperative Pain After Craniotomy in Adults
|
Phase 4 | |
Recruiting |
NCT05351229 -
Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery
|
Phase 4 | |
Enrolling by invitation |
NCT05543109 -
Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block
|
N/A | |
Completed |
NCT05346588 -
THRIVE Feasibility Trial
|
Phase 3 | |
Completed |
NCT04919317 -
Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty
|
Phase 2 |